GE HealthCare Technologies (NASDAQ:GEHC – Get Free Report) is set to release its earnings data before the market opens on Tuesday, April 30th. Analysts expect GE HealthCare Technologies to post earnings of $0.90 per share for the quarter. GE HealthCare Technologies has set its FY 2024 guidance at 4.200-4.350 EPS and its FY24 guidance at $4.20-$4.35 EPS.Persons that wish to register for the company’s earnings conference call can do so using this link.
GE HealthCare Technologies (NASDAQ:GEHC – Get Free Report) last announced its quarterly earnings data on Tuesday, February 6th. The company reported $1.18 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.07 by $0.11. The company had revenue of $5.20 billion for the quarter, compared to analysts’ expectations of $5.09 billion. GE HealthCare Technologies had a net margin of 8.02% and a return on equity of 25.58%. The business’s revenue was up 5.3% compared to the same quarter last year. During the same quarter in the previous year, the company posted $1.31 EPS. On average, analysts expect GE HealthCare Technologies to post $4 EPS for the current fiscal year and $5 EPS for the next fiscal year.
GE HealthCare Technologies Stock Performance
Shares of GEHC opened at $86.24 on Monday. The firm’s 50 day moving average is $88.92 and its 200-day moving average is $78.59. The stock has a market capitalization of $39.35 billion, a P/E ratio of 28.56, a P/E/G ratio of 3.00 and a beta of 0.94. The company has a debt-to-equity ratio of 1.18, a current ratio of 1.05 and a quick ratio of 0.83. GE HealthCare Technologies has a 12-month low of $62.35 and a 12-month high of $94.50.
GE HealthCare Technologies Announces Dividend
Analysts Set New Price Targets
Several brokerages have recently issued reports on GEHC. Evercore ISI lifted their price objective on shares of GE HealthCare Technologies from $93.00 to $100.00 and gave the stock an “outperform” rating in a research note on Thursday, April 4th. Mizuho lifted their target price on shares of GE HealthCare Technologies from $96.00 to $110.00 and gave the stock a “buy” rating in a research report on Thursday, April 11th. Morgan Stanley lifted their target price on shares of GE HealthCare Technologies from $74.00 to $86.00 and gave the stock an “equal weight” rating in a research report on Monday, February 12th. HSBC initiated coverage on shares of GE HealthCare Technologies in a research report on Thursday, February 15th. They issued a “buy” rating and a $100.00 target price on the stock. Finally, Citigroup lifted their target price on shares of GE HealthCare Technologies from $88.00 to $103.00 and gave the stock a “buy” rating in a research report on Wednesday, April 3rd. Four research analysts have rated the stock with a hold rating and seven have issued a buy rating to the company. According to data from MarketBeat.com, the company has an average rating of “Moderate Buy” and a consensus target price of $95.09.
Read Our Latest Analysis on GEHC
About GE HealthCare Technologies
GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.
Read More
- Five stocks we like better than GE HealthCare Technologies
- Want to Profit on the Downtrend? Downtrends, Explained.
- Snap Crackles and Pops on Surprise Profit and Raised Guidance
- Dividend King Proctor & Gamble Is A Buy On Post-Earnings Weakness
- MarketBeat Week in Review – 4/22 – 4/26
- Upcoming IPO Stock Lockup Period, Explained
- 3 Stocks Leading the U.S. Agriculture Comeback
Receive News & Ratings for GE HealthCare Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for GE HealthCare Technologies and related companies with MarketBeat.com's FREE daily email newsletter.